DCTH · Healthcare · $551M
$15.97+0.76%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 114 Medical - Devices peers
Quarterly Revenue Growth
“이번 분기 HEPZATO의 핵심 성장 동력은 'CHOPIN 임상 결과'예요.”
In the company's words · 2026 1분기 earnings call